Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to […]

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior energy firms UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve Nuclear energy included […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44% CNSP has sublicensed Berubicin to WPD Pharmaceuticals in […]

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

Telehealth sector going through explosive growth; patients’ data protection remains key challenge Although relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients’ data security, privacy likely to tighten as pandemic abates RYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting Telehealth is becoming increasingly popular with patients […]

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Positioned to Benefit as Studies Find CBD Oil Could Help Treat COVID-19 Effects

Medical College of Georgia research shows beneficial effects from use of CBD oil to treat COVID-19 symptoms CBD oil found to increase apelin levels in the human body, a key peptide needed to reduce lung inflammation resulting from COVID-19 PacRoots Cannabis specializes in developing premium quality strains, including plants with high CBD content, rare terpene […]

SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity

Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns Sequire subscriber base surged to 3 million active traders across 90 public companies since its 2019 inception Investor interest sent […]

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics […]

Brain Scientific (BRSF) Developing State-of-the-Art AI Diagnostic Analytics

BRSF working to improve diagnostics by leveraging AI and machine learning Cloud-based infrastructure, AI-assisted diagnostic analysis is in development phase Brain Scientific creating long-term monitoring capabilities that leads to collection of essential biomarkers Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, is working on developing […]

Asia Broadband Inc. (AABB) Is ‘One to Watch’

Asia Broadband Inc. is focused on the production, supply and sale of precious and base metals, primarily to Asian markets The company recently acquired a high potential mineral property in the state of Colima, Mexico Asia Broadband has teamed with crypto wallet creator Core State Holdings Corp. to develop the AABB Gold token, a gold-backed […]

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reimagines Technology to Create Better Cancer Outcomes

Archaic technology contributes to dismal recurrence rate in bladder cancer Imagin Medical revolutionizes the way surgeons can visualize cancer to better identify, and remove during surgery There is potential to extend this technology to virtually other endoscopic procedures The battle against cancer is too often set back by crushing blows of recurrence. The disease is […]

 

From Our Blog

The Road to Web3 & AI Takes Center Stage at Futurist 2025– Full Agenda Unveiled Ahead of Miami Debut

October 31, 2025

The Blockchain Futurist Conference Florida 2025 is preparing to ignite Miami this November 5–6, delivering a high-energy, future-forward experience where Web3, crypto, and AI collide. Now just days away, the event has officially released its full agenda, offering a first look at the groundbreaking conversations, powerhouse speakers and cultural moments set to define this year’s […]

Rotate your device 90° to view site.